rs119103288
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000127.3(EXT1):c.1016G>A(p.Gly339Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G339S) has been classified as Pathogenic.
Frequency
Consequence
NM_000127.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXT1 | NM_000127.3 | c.1016G>A | p.Gly339Asp | missense_variant | 2/11 | ENST00000378204.7 | NP_000118.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXT1 | ENST00000378204.7 | c.1016G>A | p.Gly339Asp | missense_variant | 2/11 | 1 | NM_000127.3 | ENSP00000367446 | P1 | |
EXT1 | ENST00000684189.1 | n.483G>A | non_coding_transcript_exon_variant | 2/11 | ||||||
EXT1 | ENST00000436216.2 | c.386G>A | p.Gly129Asp | missense_variant, NMD_transcript_variant | 2/6 | 3 | ENSP00000400372 | |||
EXT1 | ENST00000437196.1 | c.74-1597G>A | intron_variant, NMD_transcript_variant | 5 | ENSP00000407299 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Multiple congenital exostosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 25, 2020 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change abolishes heparan sulfate biosynthesis and disrupts the activity of the EXT1/EXT2 protein complex (PMID: 10639137, 9620772). This variant has been observed in several individuals affected with hereditary multiple osteochondromatosis (PMID: 9326317, 23439489, Invitae). ClinVar contains an entry for this variant (Variation ID: 2498). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with aspartic acid at codon 339 of the EXT1 protein (p.Gly339Asp). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and aspartic acid. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2023 | EXT1: PM1, PM2, PM5, PS4:Moderate, PP1, PP3, PP4, PS3:Supporting - |
Exostoses, multiple, type 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 1998 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at